SKYE Stock Posts

Skye Bioscience will report earnings after the market closes. View Calendar The market is expecting a ±13.0% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±6.0%. View Expected Move (Conf Call: Mar 10 4:30 PM)

Skye Bioscience will report earnings after the market closes. View Calendar The market is expecting a ±15.3% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±6.5%. View Expected Move (Conf Call: Nov 10 4:30 PM)

Skye Bioscience trades 2,262 contracts. The company has the following event: Conference Call and Webcast to Discuss CBeyond Phase 2a Topline Data on Oct 6, 2025. News: Skye Bioscience Reports Topline CBeyond Phase 2a Data from Nimacimab Monotherapy and Combination Clinical Trial